Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

PURPOSE: We assessed long-term outcomes of dexamethasone 12 mg versus 6 mg given daily for up to 10 days in patients with coronavirus disease 2019 (COVID-19) and severe hypoxaemia. METHODS: We assessed 180-day mortality and health-related quality of life (HRQoL) using EuroQoL (EQ)-5D-5L index values...

Descripción completa

Detalles Bibliográficos
Autores principales: Granholm, Anders, Kjær, Maj-Brit Nørregaard, Munch, Marie Warrer, Myatra, Sheila Nainan, Vijayaraghavan, Bharath Kumar Tirupakuzhi, Cronhjort, Maria, Wahlin, Rebecka Rubenson, Jakob, Stephan M., Cioccari, Luca, Vesterlund, Gitte Kingo, Meyhoff, Tine Sylvest, Helleberg, Marie, Møller, Morten Hylander, Benfield, Thomas, Venkatesh, Balasubramanian, Hammond, Naomi E., Micallef, Sharon, Bassi, Abhinav, John, Oommen, Jha, Vivekanand, Kristiansen, Klaus Tjelle, Ulrik, Charlotte Suppli, Jørgensen, Vibeke Lind, Smitt, Margit, Bestle, Morten H., Andreasen, Anne Sofie, Poulsen, Lone Musaeus, Rasmussen, Bodil Steen, Brøchner, Anne Craveiro, Strøm, Thomas, Møller, Anders, Khan, Mohd Saif, Padmanaban, Ajay, Divatia, Jigeeshu Vasishtha, Saseedharan, Sanjith, Borawake, Kapil, Kapadia, Farhad, Dixit, Subhal, Chawla, Rajesh, Shukla, Urvi, Amin, Pravin, Chew, Michelle S., Wamberg, Christian Aage, Bose, Neeta, Shah, Mehul S., Darfelt, Iben S., Gluud, Christian, Lange, Theis, Perner, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970069/
https://www.ncbi.nlm.nih.gov/pubmed/35359168
http://dx.doi.org/10.1007/s00134-022-06677-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970069/
https://www.ncbi.nlm.nih.gov/pubmed/35359168
http://dx.doi.org/10.1007/s00134-022-06677-2

Ejemplares similares